Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: Study design of the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events post-acute cOroNary sYndromes (SYMPHONY) trial

✍ Scribed by L.Kristin Newby

• Book ID: 117011186
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 96 KB
• Volume: 138
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/s0002-8703(99)70104-3